Transforming Diagnostics: The Evolving Operational Delivery of Point-of-Care Testing and Care Models

Synopsis

Point-of-care testing (POCT) and diagnostics are undergoing a rapid transformation driven by evolving healthcare demands, technological innovations, and service delivery reforms. These changes aim to bring diagnostics closer to patients, streamline workflows, and improve outcomes while managing costs effectively.

This article explores key trends shaping this landscape, including Managed Equipment Services (MES), large regional tenders, community-based testing models, patient self-testing, mobile diagnostics, and the integration of informatics and business intelligence. The goal is to provide a broad, strategic view of how diagnostics are being reimagined across the continuum of care.

---

1. Managed Equipment Services: Streamlining Diagnostic Infrastructure

Managed Equipment Services (MES) have emerged as a strategic model to deliver, manage, and maintain medical diagnostic equipment—often under long-term agreements with private partners. MES offers several operational and financial benefits, although it introduces trade-offs that must be carefully evaluated. These contracts are nothing new but with the formation of large geographical networks, their use is set to become the standard of future procurement and service delivery.

Risk Management and Primary Contract Provider

MES transfers much of the operational risk from the healthcare provider to the service partner. This includes equipment maintenance, upgrades, replacement cycles, and ensuring uptime. By appointing a primary contract provider, healthcare organisations reduce the administrative burden of managing multiple vendors, improving service continuity and responsiveness.

VAT Efficiency and Commercial Advantages

NHS trusts and other healthcare bodies benefit from VAT recovery advantages under MES contracts, which can reduce costs compared to direct capital purchases, especially initial financial outlay. MES often includes financing mechanisms that spread out costs and align them with usage, thus improving capital efficiency.

Improved Efficiency vs. Reduced Choice

Standardisation under MES can improve efficiency, equipment training, and support but can also limit device choice. This trade-off may stifle innovation or hinder adoption of newer technologies during the contract period. It would be beneficial for all contracts to include a clause that allows the service to adopt a preferred alternative solution if the performance of the primary contract solution is proven to be sub-optimal.

---

2. Regional Tenders and the Push for Standardisation

Large diagnostic tenders covering wide geographical regions are becoming more common across integrated care systems (ICS) and networks. These contracts aim to reduce fragmentation and drive cost savings by standardising services and devices. This benefits patients within that region so that the same care is received across all organisations within that region, reducing variation.

Cost Avoidance and Operational Cohesion

By bundling services and standardising procurement, organisations can avoid unnecessary costs, negotiate better pricing, and reduce variability in diagnostic practice. This can improve training, data integration, and equipment maintenance. It also offers a significant contingency benefit if patient samples can be performed at multiple sites using the same equipment and reporting parameters.

Innovation and Risk of Legacy Technology

While these long-term contracts often include extension clauses, they can create inertia. Providers may be “stuck” with legacy systems, especially when newer, more effective diagnostics become available mid-contract. However, larger tenders also create a platform for innovation, allowing novel solutions to scale across entire regions. Timing is key to adopting new medical technology. With the formation of networks, many sites will be committed to overlapping legacy contracts, and moving to one network-wide contract may take years to align without paying for expensive release clauses.

---

3. Community-Based Teams and Decentralised Diagnostics

The NHS and other healthcare systems are investing in community-based diagnostic teams who provide services directly in patients’ homes or nearby clinics. This model supports early intervention, chronic disease monitoring, and discharge planning.

Benefits and Scope Expansion

Community-based teams can perform a wide range of diagnostic tests including blood and urine tests, respiratory assessments, and even portable imaging. This improves access, particularly for elderly, immobile, or vulnerable populations. It also supports population health initiatives under Primary Care Networks (PCNs).

Integration with ICS and PCN Goals

These teams align with goals of integrated care systems (ICS) by shifting diagnostics upstream, reducing hospital burden, and creating localised diagnostic pathways that are more responsive to population health needs. These initiatives put the patient experience first, reducing the disruption and cost associated with patients visiting hospital clinic appointments.

---

4. Patient Self-Testing: Empowering the Individual

One of the most exciting advancements in diagnostics is the emergence of patient self-testing as a routine part of chronic disease management and preventive care.

Monitoring Chronic Conditions at Home

Self-testing allows patients to monitor diabetes, coagulation (INR), kidney function, and respiratory conditions at home using user-friendly devices. Results can be uploaded through mobile apps or portals, with clinical teams alerted if thresholds are breached.

Preventing Re-admissions and Improving Step-Down Care

This approach supports step-down care for patients recently discharged and helps avoid unnecessary re-admissions. Real-time data sharing allows clinicians to adjust treatment remotely, improving outcomes while reducing hospital pressure.

Patient Satisfaction and Health Outcomes

Studies show self-testing improves patient engagement, adherence, and satisfaction. It provides a sense of control and reduces travel and waiting times—critical for individuals with mobility or transport challenges. One thing that is often forgotten is that patients often have pets that need to be taken care of if a patient is in hospital, along with the pain of separation the patient will experience.

---

5. Community Diagnostic Hubs: Bringing Testing Closer to Home

Community Diagnostic Centres (CDCs) and Hubs linked to PCNs and ICB boundaries are becoming essential to the NHS Long Term Plan. We also await the release of the 10 year plan document which will outline the system transformation planned to improve patient care, system efficiency and health outcomes, shifting the focus to prevention and pre-hospital care.

Role and Impact

These hubs offer “one-stop shops” for diagnostics like blood tests, imaging, ECGs, and even basic procedures. Sometimes co-located with GP surgeries or local health centres, they reduce pressure on hospitals while improving access to diagnostics.

Strategic Fit

Community hubs support early diagnosis, reduce outpatient backlogs, and are geographically positioned to serve specific integrated care board (ICB) footprints. They also integrate well with care coordination models, streamlining referral and reporting. One challenge is to ensure each ICB adheres to the principles of the national strategy which requires effective, positive leadership throughout the structure.

---

6. Mobile Testing Units: Reaching Underserved Populations

Mobile diagnostics provide access to essential tests in hard-to-reach or underserved areas, particularly in urban, rural, or transient populations.

Flexible Service Delivery

Mobile units are deployed for infectious diseases (e.g., COVID-19, flu), sexually transmitted infections (STIs), ultrasound, X-rays, ECGs, and phlebotomy. These units are often linked to public health initiatives, screening campaigns, and disaster response efforts.

Improved Equity and Outreach

Mobile diagnostics ensure equity in access by visiting schools, prisons, care homes, workplaces, and rural communities, often in collaboration with local authorities or community groups.

---

7. Informatics and Middleware: Linking Modern Diagnostics

Advances in informatics and middleware platforms are critical enablers of decentralised and mobile diagnostics. Market leaders are committed to developing solutions that are patient focussed, circumvent historic information technology (IT) barriers and are easy to install, providing an open architecture to connect medical devices.

Enhanced Connectivity

Modern middleware systems integrate POCT devices with electronic patient records (EPRs), laboratory information systems (LIS), and hospital IT infrastructure. This ensures test results are accessible to all stakeholders in real time.

Mobile Apps and Portals

Patients and clinicians increasingly use mobile apps and web portals to access diagnostic results, schedule appointments, and manage care plans. This supports remote monitoring, telehealth, and virtual clinics, driving efficiency and engagement.

---

8. Business Intelligence and Decision Support Tools

Data from diagnostic devices is no longer viewed in isolation. Business Intelligence (BI) platforms now aggregate, analyse, and visualise diagnostic data to support clinical and operational decisions. Clinical teams can define their local pathways and algorithms within the provider’s solution, providing a responsive clinical tool.

Examples and Use Cases

• Predictive analytics to identify at-risk patients based on set inclusion criteria
• Dashboarding tools for performance monitoring and service delivery, fully customisable to reflect what is deemed important to the service provider
• Clinical decision support (CDS) that provides interpretation and recommends next steps based on test results

These tools improve clinical accuracy, resource allocation, and long-term care planning.

---

9. POCT Services as Business Units: A New Operating Model

An emerging model is to operate POCT services as semi-autonomous business units within healthcare organisations. This includes taking responsibility for:

• Financial performance
• Key performance indicator (KPI) review and management
• Budget setting, workforce planning and cost effectiveness analysis
• Cross-charging – Staff training and quality assurance
• Device lifecycle and maintenance
• Compliance with MHRA/ISO standards
• Operational and clinical data management and audit readiness

This entrepreneurial approach aligns POCT delivery with business objectives, fosters innovation, and enhances accountability. There is currently an interest in adopting the services of independent POCT consultants in delivering system changes at pace, supporting NHS teams in delivering excellence.

Further Reading

For a deeper dive into this model, see the article: The need for point of care teams to operate as a business unit

---

Conclusion: A Converging Diagnostic Ecosystem

The diagnostics landscape is undergoing a tectonic shift, driven by integrated care strategies, technology, and a strong push toward community-based services. Point-of-care testing is no longer confined to clinical settings—it is part of a broader, more dynamic ecosystem that includes homes, communities, mobile units, and the integration of cloud platforms.

Although there is current uncertainty, the success of this transformation hinges on robust infrastructure, smart procurement models like MES and mini competitions, cohesive informatics, and empowered patients. Healthcare organisations must adapt quickly, embrace innovation, and build flexible diagnostic pathways that reflect the needs of the population—not just the limitations of legacy systems.

For more insights contact POCTInnovators through either LinkedIn or www.POCTInnovators.com